TD Cowen analyst Charles Rhyee downgraded DarioHealth (DRIO) to Hold from Buy with a price target of $1, down from $2. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on DRIO: DarioHealth closes $25.6M private placement DarioHealth announces collaboration with MediOrbis